Bay Harbor Wealth Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.4K Buy
16
+5
+45% +$544 ﹤0.01% 604
2026
Q1
$1.02K Buy
11
+3
+38% +$301 ﹤0.01% 771
2025
Q4
$817 Buy
8
+2
+33% +$179 ﹤0.01% 694
2025
Q3
$374 Buy
6
+4
+200% +$218 ﹤0.01% 834
2025
Q2
$104 Buy
2
+1
+100% +$45 ﹤0.01% 1100
2025
Q1
$42 Buy
+1
New +$43 ﹤0.01% 1047

Other funds holding GH

Bay Harbor Wealth Management's GH Position: Q2 2026 in Review

Bay Harbor Wealth Management increased its Guardant Health (GH) stake by 45% in Q2 2026, buying an estimated $544 and bringing the position to 16 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #604.

Bay Harbor Wealth Management first reported a position in GH in Q1 2025 and has held it in 6 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Bay Harbor Wealth Management held 16 shares of Guardant Health worth $2.4K as of Q2 2026.
  • Bay Harbor Wealth Management bought 5 Guardant Health shares in Q2 2026, an estimated $544.
  • Guardant Health made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #604 holding.
  • Bay Harbor Wealth Management first reported a position in Guardant Health in Q1 2025 and has held it in 6 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.